TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer March 26, 2010
TCL Archive NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center. December 7, 2001
TCL Archive In Brief: Leaks From Cooperative Group Site Visits Vex CCIRC; Tumor Cell Cloning Workshop Set August 11, 1978
